Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1958 2
1959 2
1961 1
1967 1
1968 1
1977 1
1978 2
1979 1
1984 3
1985 2
1986 1
1990 1
1996 1
2004 1
2006 2
2007 3
2008 6
2009 3
2010 5
2011 5
2012 4
2013 8
2014 5
2015 6
2016 8
2017 5
2018 4
2019 6
2020 9
2021 9
2022 7
2023 2
2024 1
2025 3
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.
Rathmell WK, Rumble RB, Van Veldhuizen PJ, Al-Ahmadie H, Emamekhoo H, Hauke RJ, Louie AV, Milowsky MI, Molina AM, Rose TL, Siva S, Zaorsky NG, Zhang T, Qamar R, Kungel TM, Lewis B, Singer EA. Rathmell WK, et al. Among authors: molina am. J Clin Oncol. 2022 Sep 1;40(25):2957-2995. doi: 10.1200/JCO.22.00868. Epub 2022 Jun 21. J Clin Oncol. 2022. PMID: 35728020
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.
Nguyen DD, Hooper WF, Liu W, Chu TR, Geiger H, Shelton JM, Shah M, Goldstein ZR, Winterkorn L, Helland A, Sigouros M, Manohar J, Moyer J, Al Assaad M, Semaan A, Cohen S, Madorsky Rowdo F, Wilkes D, Osman M, Singh RR, Sboner A, Valentine HL, Abbosh P, Tagawa ST, Nanus DM, Nauseef JT, Sternberg CN, Molina AM, Scherr D, Inghirami G, Mosquera JM, Elemento O, Robine N, Faltas BM. Nguyen DD, et al. Among authors: molina am. Nature. 2024 Nov;635(8037):219-228. doi: 10.1038/s41586-024-07955-3. Epub 2024 Oct 9. Nature. 2024. PMID: 39385020 Free PMC article.
Rare T-cell lymphomas.
Molina AM, Horwitz SM. Molina AM, et al. Cancer Treat Res. 2008;142:331-47. doi: 10.1007/978-0-387-73744-7_14. Cancer Treat Res. 2008. PMID: 18283793 Review.
Smart Targeting To Improve Cancer Therapeutics.
Morales-Cruz M, Delgado Y, Castillo B, Figueroa CM, Molina AM, Torres A, Milián M, Griebenow K. Morales-Cruz M, et al. Among authors: molina am. Drug Des Devel Ther. 2019 Oct 30;13:3753-3772. doi: 10.2147/DDDT.S219489. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31802849 Free PMC article. Review.
Targeting renal cell carcinoma.
Motzer RJ, Molina AM. Motzer RJ, et al. Among authors: molina am. J Clin Oncol. 2009 Jul 10;27(20):3274-6. doi: 10.1200/JCO.2009.21.8461. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451422 No abstract available.
Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.
Kuo HH, Bhinder B, Gokozan HN, Gorski K, Chandra P, Manohar J, Guevara D, Otilano J, Moyer J, Tranquille M, Ackermann S, Capuano J, Cheung C, Caiazza TA, Reuben PL, Tsomides AM, Irizarry A, Sigouros M, Wilkes D, King A, Kane T, Al Assaad M, Al Zoughbi W, Ohara K, Auh J, Waltman P, Madorsky Rowdo FP, Podaza E, Gallegos V, Nguyen J, Shah R, Shah M, Ocean A, Scherr D, Altorki N, Frey M, Molina AM, Newman L, Bea V, Chapman-Davis E, Goncalves MD, Saxena A, Shukla PJ, Holcomb K, Simmons R, Tagawa S, Zippin JH, Cantillo E, Chandwani R, Davis M, Garrett K, Kasi PM, Marti J, Nanus D, Nauseef JT, Popa E, Siddiqui MT, Alonso A, Sternberg CN, Faltas BM, Elemento O, Mosquera JM, Sboner A, Martin ML. Kuo HH, et al. Among authors: molina am. Sci Adv. 2026 Jun 26;12(26):eadz3351. doi: 10.1126/sciadv.adz3351. Epub 2026 Jun 26. Sci Adv. 2026. PMID: 42361179 Free PMC article.
Clonal evolution of chemotherapy-resistant urothelial carcinoma.
Faltas BM, Prandi D, Tagawa ST, Molina AM, Nanus DM, Sternberg C, Rosenberg J, Mosquera JM, Robinson B, Elemento O, Sboner A, Beltran H, Demichelis F, Rubin MA. Faltas BM, et al. Among authors: molina am. Nat Genet. 2016 Dec;48(12):1490-1499. doi: 10.1038/ng.3692. Epub 2016 Oct 17. Nat Genet. 2016. PMID: 27749842 Free PMC article.
mTOR inhibitors in advanced renal cell carcinoma.
Voss MH, Molina AM, Motzer RJ. Voss MH, et al. Among authors: molina am. Hematol Oncol Clin North Am. 2011 Aug;25(4):835-52. doi: 10.1016/j.hoc.2011.04.008. Hematol Oncol Clin North Am. 2011. PMID: 21763970 Free PMC article. Review.
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution.
Nagar H, Diven MA, Rippon B, Barbieri CE, Hu JC, Scherr DS, Yadav P, Tshering L, Chandrasekhar S, Wolfe S, Pennell R, Coonce M, Chen SL, Formenti SC, Strong P, Davicioni E, Molina AM, Nanus DM, Nauseef JT, Sternberg CN, Zhou XK, Lei W, Osborne JR, Marciscano AE, Tagawa ST. Nagar H, et al. Among authors: molina am. Eur Urol Oncol. 2026 Apr;9(2):286-293. doi: 10.1016/j.euo.2025.05.014. Epub 2025 Jun 10. Eur Urol Oncol. 2026. PMID: 40494733 Free PMC article. Clinical Trial.
109 results